This study assessed the efficacy of iloprost in relieving vasospasm in coronary artery bypass grafts. Radial artery (RA), left internal thoracic artery (LITA) and saphenous vein (SV) grafts were taken from 20 patients (13 men and seven women, mean age 63.8 years [range 48 -74 years]) scheduled to undergo coronary artery bypass grafting. Ten 3 mm vascular rings were cut from each graft and kept under tension for at least 60 min. They were kept alive with 37 ºC oxygenated Krebs solution. Smooth muscle contraction was achieved with phenylephrine before iloprost was administered every 2 min, starting at a concentration of 10 -9 mol/l and increasing in logarithmic increments to a concentration of 10 -5 mol/l. The vasodilation response to iloprost started in all samples at a concentration of 10 -9 mol/l and increased with each incremental increase in iloprost concentration up to 10 -5 mol/l. These data suggest that local administration of iloprost has a role in relieving graft vasospasm during harvesting and preparation for coronary artery bypass grafting.
Introduction
The importance of coronary artery bypass grafting (CABG) has increased owing to the rising incidence of cardiovascular disease. Myocardial ischaemia can be relieved by the application of grafts obtained from the left internal thoracic artery (LITA), radial artery (RA) and/or saphenous vein (SV). The choice of whether to use mechanical vasodilatation, pharmacological agents or both at harvesting and during preparation of the graft can be critical to the long-term patency. 1 Spasm of arterial or venous grafts before attachment can negatively influence outcomes and several studies have investigated ways of preventing its occurrence. 1,2 Topical application of vasodilators, such as papaverine, diltiazem and nitroglycerine, to grafts shows promising results 2 and is widely employed. Data on iloprost, however, which also has vasodilatory properties and is used in the treatment of pulmonary hypertension and peripheral arterial disease, are sparse. 3, 4 The aim of the present study, therefore, was to evaluate the efficacy of iloprost in the relief of vasospasm in CABG.
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Patients and methods
STUDY DESIGN AND PATIENT SELECTION
The present study was carried out between March and July 2009 at the Department of Cardiovascular Surgery, Trakya University Medical Faculty, Edirne, Turkey, on consecutive patients with stable or unstable angina pectoris who underwent elective CABG surgery. Patients who underwent emergency surgery or where grafts were damaged during harvesting were excluded from the study.
The Ethics Committee of Trakya University Medical Faculty provided approval for the present study and all patients who were included provided written informed consent for participation.
HARVESTING OF GRAFTS
The decision on the type of graft depended on each patient's characteristics, surgeon preference and angiographic characteristics. Samples of all three types of graft (LITA, RA and SV) were taken from some patients, whereas in others only one type of sample graft was collected.
Dissection scissors were used to harvest grafts. The LITA and RA grafts were taken together with some surrounding vein, muscle fascia and adipose tissues since they are prone to vasospasm, whereas the SV grafts are not prone to vasospasm so were collected without surrounding tissue. If vasospasm occurred, pressurized saline was applied to relieve the spasm. The SV grafts were collected without inflation to avoid barotraumas. None of the grafts was exposed to vasodilatory drugs before harvesting although, due to over-reactivity of arterial grafts, local vasodilatory drugs were used on the LITA and RA grafts at harvesting, according to standard procedure at the Department of Cardiovascular Surgery, Trakya University Medical Faculty. The whole grafts were transported to the vascular laboratory in 4°C Krebs solution (composition: 122 mmol/l saline, 5 mmol/l potassium chloride, 1.25 mmol/l calcium chloride, 25 mmol/l sodium bicarbonate, 1.2 mmol/l magnesium sulphate, 1.0 mmol/l potassium dihydrogen phosphate and 11.5 mmol/l glucose) that was continuously aerated with 95% oxygen and 5% carbon dioxide. The grafts were long enough to allow enough tissue for the study and for surgery.
SAMPLE COLLECTION AND ANALYSIS
Each graft was dissected from the adjacent tissues and under the microscope was sliced into rings 3 mm in width. The vascular rings were suspended in classic tissue baths on steel hooks attached to transducers (FDT-10-A force displacement transducer; Commat, Ankara, Turkey), to which 1 -4 g active tension was applied to the upper end for a minimum of 60 min while the lower end was kept stable. The samples were kept alive by being bathed in 37°C oxygenated Krebs solution which was changed every 20 min to keep them alive. In order to measure relaxation response, samples were exposed in situ in the tissue baths to phenylephrine (Fenilefrin; Merck, Istanbul, Turkey) to induce constriction, then iloprost (Ilomedin ® ampule; Bayer Schering, Berlin, Germany) was administered every 2 min, starting at a concentration of 10 -9 mol/l and increasing in logarithmic increments to a concentration of 10 -5 mol/l. Dose-response data were obtained via a transducer acquisition system (TDA-97; Commat) and stored in Polwin 97 software (Commat).
STATISTICAL ANALYSIS
Graphpad Prism 4 software (Graphpad T Ege, O Gur, CH Karadag et al.
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Software, La Jolla, CA, USA) was used to construct dose-response curves and to perform non-linear regression. The doseresponse curves obtained with iloprost on RA, LITA and SV were constructed by nonlinear regression and comparisons between the curves for the parameters of log EC 50 (where EC 50 is the dose that gives 50% of maximum relaxation) and maximum relaxation (E max ) were performed by the extra sum-of-squares F-test. A value of P < 0.05 represented the cut-off for significance.
Results
Twenty patients (13 men and seven women) of mean ± SD age 63.8 ± 8.2 years (range 48 -74 years) were included in the study. Samples of LITA graft were collected from all 20 patients but only 10 samples were viable for study; the remaining 10 graft samples were not alive. Samples of RA graft were collected from 12 patients but only 10 of the samples were tested to be alive and were, therefore, included in the study. Samples of SV graft were collected from 11 patients, of which one sample was not viable; the remaining 10 viable samples were studied. Each type of graft, therefore, had 10 viable samples for study.
In all three types of graft, a relaxation response was seen at an iloprost concentration of 10 -9 mol/l and this increased in a sigmoid manner with increasing concentrations of iloprost up to 10 -5 mol/l iloprost (Fig. 1) . The mean ± SD values for E max for each type of sample were calculated as: RA 119.40 ± 1.65%, LITA 101.50 ± 1.56% and SV 96.99 ± 1.75%. The relaxation response in the RA samples was significantly higher than in the LITA and SV graft samples (P < 0.05). The mean ± SD log EC 50 values were: RA -8.43 ± 0.14, LITA -9.79 ± 0.59 and FIGURE 1: Dose-relaxation response curves for 10 radial artery, 10 left internal thoracic artery and 10 saphenous vein graft samples, obtained from 20 patients undergoing coronary artery bypass graft and treated with 10 -9 -10 -5 mol/l iloprost after tension was mechanically induced for at least 60 min. The relaxation response (E max ) in the radial artery samples was significantly higher than in the left internal thoracic artery and saphenous vein graft samples (P < 0.05) 
Discussion
The excellent long-term patency achieved with LITA and RA grafts means they are readily used in CABG. The long-term outcomes with SV grafts are not as good as those for arterial grafts, but easy access for harvesting the desired length of vessel, rapid preparation times and high early flow rates means they are frequently used. 5 Outcomes for all types of grafts could, however, be improved if spasm of the graft during preparation could be prevented or relieved.
Iloprost is a stable, potent prostacyclin analogue that is widely used to relieve vasoconstriction in patients with pulmonary hypertension and peripheral arterial disease, owing to its ability to relax smooth muscle. 6 -12 Intravenous or inhaled administration of this agent can be lifesaving in these patients. 13, 14 This drug could, therefore, have potential for use in preparation for CABG. Ustunsoy et al. 15 showed that mid-term graft patency was better in grafts that had been treated with iloprost to prevent vasospasm than in those treated with diltiazem. Not all results have, however, been consistent. Ozdemir et al. 3 demonstrated that iloprost is a more potent vasodilator than diltiazem and is as effective as papaverine in RA grafts. By contrast, Serbest et al. 4 found that iloprost had weaker vasodilatory effects than papaverine and diltiazem in isolated ITA samples.
Krause and Krais 16 reported that an iloprost infusion administered at a rate of 1 ng/kg per min for 45 min yielded drug concentrations in blood of 46 ± 8 pg/ml and that administration at 3 ng/kg per min yielded concentrations of 135 ± 24 pg/ml. The present in vitro study used iloprost at concentrations of 10 -9 -10 -5 mol/l, which would lead to blood concentrations of 478.6 pg/ml -4.789 µg/ml. These levels are above the therapeutic range of iloprost.
In the present study, the vasodilatory effects of iloprost were found to be significantly more pronounced in RA grafts than in the other two graft types. The relaxation responses to iloprost in LIMA and SV grafts were similar, which is a new finding, as previous studies have compared only LITA and RA grafts. 3, 4 In conclusion, iloprost led to local vasodilation in all three types of grafts for CABG. These data suggest that local administration of iloprost has a role in relieving graft vasospasm during harvesting and preparation for CABG.
